Driehaus Capital Management LLC Aerie Pharmaceuticals Inc Transaction History

Driehaus Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$47.85 - $70.45 $791,391 - $1.17 Million	-16,539 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$51.15 - $61.0 $3.04 Million - $3.63 Million	-59,456 Reduced 78.24%	16,539 $897,000
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $1.09 Million - $1.4 Million	-21,523 Reduced 22.07%	75,995 $4.54 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $4.74 Million - $5.86 Million	97,518	97,518 $4.74 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.